BIOMAT Database Logo BIOMAT Database Logo

Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy. 1987

A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Department of Ophthalmology, Jikei University School of Medicine, Tokyo, Japan.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D002386 Cataract Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed) Cataract, Membranous,Lens Opacities,Pseudoaphakia,Cataracts,Cataracts, Membranous,Lens Opacity,Membranous Cataract,Membranous Cataracts,Opacities, Lens,Opacity, Lens,Pseudoaphakias
D003921 Diabetes Mellitus, Experimental Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY. Alloxan Diabetes,Streptozocin Diabetes,Streptozotocin Diabetes,Experimental Diabetes Mellitus,Diabete, Streptozocin,Diabetes, Alloxan,Diabetes, Streptozocin,Diabetes, Streptozotocin,Streptozocin Diabete
D000449 Aldehyde Reductase An enzyme that catalyzes reversibly the oxidation of an aldose to an alditol. It possesses broad specificity for many aldoses. EC 1.1.1.21. Aldose Reductase,Aldose Reductase Ia,Aldose Reductase Ib,Erythrose Reductase,Xylose Reductase,Reductase Ia, Aldose,Reductase Ib, Aldose,Reductase, Aldehyde,Reductase, Aldose,Reductase, Erythrose,Reductase, Xylose
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013059 Spectrum Analysis, Raman Analysis of the intensity of Raman scattering of monochromatic light as a function of frequency of the scattered light. Raman Spectroscopy,Analysis, Raman Spectrum,Raman Optical Activity Spectroscopy,Raman Scattering,Raman Spectrum Analysis,Scattering, Raman,Spectroscopy, Raman
D013401 Sugar Alcohol Dehydrogenases Reversibly catalyzes the oxidation of a hydroxyl group of sugar alcohols to form a keto sugar, aldehyde or lactone. Any acceptor except molecular oxygen is permitted. Includes EC 1.1.1.; EC 1.1.2. and EC 1.1.99. Sugar Alcohol Oxidoreductases,Alcohol Dehydrogenases, Sugar,Alcohol Oxidoreductases, Sugar,Dehydrogenases, Sugar Alcohol,Oxidoreductases, Sugar Alcohol
D048289 Imidazolidines Compounds based on reduced IMIDAZOLINES which contain no double bonds in the ring. Imidazolidine
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
November 1991, Investigative ophthalmology & visual science,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
January 1985, Diabetes,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat.
December 2006, Diabetologia,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy.
January 1990, Diabete & metabolisme,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
[Prevention of experimental diabetic corneal endotheliopathy with aldose reductase inhibitor].
February 1987, Nippon Ganka Gakkai zasshi,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
[Prefeeding of aldose reductase inhibitor inhibits galactose cataract].
April 1993, Nippon Ganka Gakkai zasshi,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Glucocorticoid-induced cataract in chick embryo monitored by Raman spectroscopy.
January 1989, Investigative ophthalmology & visual science,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of an aldose reductase inhibitor on diabetic peripheral neuropathy. Preliminary report.
February 1981, Archives of neurology,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of an aldose reductase inhibitor on esophageal dysfunction in diabetic patients.
January 2005, Hepato-gastroenterology,
A Mizuno, and H Nozawa, and T Yaginuma, and H Matsuzaki, and Y Ozaki, and K Iriyama
Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of rat.
September 2001, Neuroscience letters,
Copied contents to your clipboard!